PAVmed (PAVM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual meeting scheduled for June 24, 2026, to be held virtually at 10:00 a.m. Eastern time.
Stockholders can access proxy materials and vote electronically using a 12-digit control number.
Proxy materials, including the annual report and proxy statement, are available online, with options to request paper or email copies.
Voting matters and shareholder proposals
Election of two Class A directors to serve until the third succeeding annual meeting.
Approval of amendments to the Employee Stock Purchase Plan to increase available shares and raise the annual limit for the evergreen provision.
Ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
Board recommends voting "FOR" all management proposals.
Board of directors and corporate governance
Two board seats (Class A directors) are up for election, with terms extending to the third succeeding annual meeting.
Latest events from PAVmed
- Shareholders to vote on director elections, ESPP expansion, and auditor ratification at the annual meeting.PAVM
Proxy filing1 May 2026 - Registering 9.2M shares for resale after a $30M private placement; proceeds fund operations.PAVM
Registration filing21 Apr 2026 - Restructuring and recapitalization drove growth, improved financials, and expanded diagnostic access.PAVM
Q4 20252 Apr 2026 - Record test growth and revenue surge, but losses and funding risks persist.PAVM
Q2 202426 Mar 2026 - Q1 2025 net income reached $17.7M as Lucid and Veris advanced, but going concern risks persist.PAVM
Q1 202526 Mar 2026 - Stabilized finances, advanced diagnostics, and expanded digital health amid ongoing capital needs.PAVM
Q3 202526 Mar 2026 - Q2 2025 featured 2,756 EsoGuard tests, $1.2M revenue, and strengthened liquidity.PAVM
Q2 202526 Mar 2026 - Votes are sought on stock issuance, governance changes, and expanded equity incentives.PAVM
Proxy Filing24 Feb 2026 - Proxy seeks approval for stock issuance, charter amendment, and expanded equity plan.PAVM
Proxy Filing13 Feb 2026